SEC 13F Intelligence

Innovis Asset Management LLC / VRTX

Innovis Asset Management LLC’s Vertex Pharmaceuticals Inc Position

Does Innovis Asset Management LLC own Vertex Pharmaceuticals Inc (VRTX)? Yes — 22.5K shares worth $8M (+3.01% of its 13F portfolio) as of Q3 2023, down from 22.5K shares the prior filed quarter.

Position Value
$8M
Q3 2023
Shares
22.5K
% of Portfolio
+3.01%
Quarters Held
4
currently held

Position History VRTX

Reported value by quarter
Q4 ’22: $4MQ4 ’22Q1 ’23: $6MQ1 ’23Q2 ’23: $8MQ2 ’23Q3 ’23: $8MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202322.5K$8M+3.01%
Q2 202322.5K$8M+2.93%
Q1 202318.6K$6M+2.37%
Q4 202213.1K$4M+1.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Innovis Asset Management LLC’s full portfolio or all institutional holders of VRTX.